Drugs & Targets FDA approves Sarclisa in patients with previously treated MM March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants tipifarnib Fast Track designation in T-cell lymphomas March 06, 2020Vol.46 No.10
Clinical Roundup Phase III BOSTON study meets primary endpoint with significant increase in PFS March 06, 2020Vol.46 No.10
Clinical Roundup Keytruda meets PFS primary endpoint in phase III KEYNOTE-204 March 06, 2020Vol.46 No.10
Clinical Roundup From scorpion to immunotherapy: City of Hope scientists repurpose toxin for first-of-its kind CAR-T cell therapy for brain tumors March 06, 2020Vol.46 No.10
